Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9821045 Controlled delivery of TLR3 agonists in structural polymeric devices

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Glenn Dranoff0

Omar Abdel-Rahman Ali0

David J. Mooney0

Date of Patent

November 21, 2017

Patent Application Number

15135216

Date Filed

April 21, 2016

Patent Citations Received

US Patent 12108225 Implantable device for sustained release of a macromolecular drug compound

0

US Patent 11690806 Implantable device for sustained release of a macromolecular drug compound

0

US Patent 11690807 Implantable device for sustained release of a macromolecular drug compound

0

US Patent 11752238 Recapitulating the hematopoietic niche to reconstitute immunity

US Patent 11786457 Peritumoral and intratumoral materials for cancer therapy

US Patent 11951215 Implantable device for sustained release of a macromolecular drug compound

0

US Patent 11998593 Combination vaccine devices and methods of killing cancer cells

0

Patent Primary Examiner

Elly-Gerald Stoica

Patent abstract

The present invention comprises compositions, methods, and devices for creating an stimulating an antigen-specific dendritic cell immune response. Devices and methods provide prophylactic and therapeutic immunity to subjects against cancer and infectious agents.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9821045 Controlled delivery of TLR3 agonists in structural polymeric devices

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool